Patent · US Active

CTLA4 proteins and their uses

US8883971B2 · kind B2 · utility

5Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2013
Grant dateNov 11, 2014
Priority date—
Expiry dateAug 15, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.